Muscle Cramp Clinical Trial
— CramPOfficial title:
Prevention of Leg Cramps Using Compression Stockings or Magnesium Supplements in the Age Group of 50 to 84: a Study Protocol for a Randomised Controlled Trial
Leg cramps are painful sensations of tightening in the muscles of the legs, that are often associated with secondary insomnia. They are common especially at an older age. There is no evidence that any method of prevention of nocturnal leg cramps would be both safe and effective. There are no previous trials concerning cramp prevention by using compression stockings. The objective of this study is to assess in a prospective randomised controlled trial whether leg cramps can be prevented by daily use of knee-length compression stockings or magnesium supplements.
Status | Not yet recruiting |
Enrollment | 225 |
Est. completion date | December 31, 2021 |
Est. primary completion date | July 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 84 Years |
Eligibility | Inclusion Criteria: - Minimum of two leg cramps per week in the past four weeks. - Age from 50 to 84 years. Exclusion Criteria: - Peripheral artery disease (confirmed or suspected). - Peripheral artery bypass surgery. - Grave peripheral neuropathy or any sensory disorder. - Allergy to the material of the compression stockings. - Grave renal failure (GFR under 30 ml/min). - The use of a magnesium carbonate product (e.g. Rennie® or Berocca®). - Cardiac failure with pulmonary oedema or massive lower limb swelling. - Lower limb soft tissue problems, including skin transplant, thinned skin, varicose ulcer, necrosis and any infection. - Lower limb deformity or atypical shape or size that could prevent the usage of compression stockings. - Continuous usage of compression stockings for any other reason than leg cramps. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Tampere University Hospital | Tampere University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The change in quantity of leg cramps | The change in quantity of leg cramps from the four-week follow-up period (prior to the intervention) to the four-week intervention period will be assessed on the basis of the participants' responses to the survey. The number of cramps will be recoded on a weekly online survey during four weeks before intervention and during the four-week intervention period. The change in the number of cramps from the four-week period prior the intervention to the intervention period will be calculated. The difference between groups will be analyzed by one-way analysis of variance of repeated measurements. | 8 weeks | |
Secondary | The change in intensity of leg cramps | The possible change in the intensity of leg cramps from the four-week follow-up period (prior to the intervention) to the four-week intervention period will be assessed on the basis of the participants' responses to the survey. The intensity of cramps will be recoded on a weekly online survey during the four weeks before intervention and during the four-week intervention period. The possible change in the intensity of cramps from the four-week period prior the intervention to the intervention period will be assessed. | 8 weeks | |
Secondary | The change in quantity of nocturnal awakening due to the cramps | The change in the quantity of nocturnal awakenings due to the cramps from the four-week follow-up period (prior to the intervention) to the four-week intervention period will be assessed on the basis of the participants' responses to the survey. The number of cramps will be recoded on a weekly online survey during four weeks before intervention and during the four-week intervention period. The change in the number of nocturnal awakenings due to the cramps from the four-week period prior the intervention to the intervention period will be calculated. The difference between groups will be analyzed by one-way analysis of variance of repeated measurements. | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04998305 -
TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps
|
Phase 1/Phase 2 | |
Completed |
NCT03176966 -
Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
|
Phase 4 | |
Completed |
NCT04575090 -
7 Tesla MRI Study in Patients With Statin Related Muscle Complaints
|
N/A | |
Completed |
NCT01271660 -
A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis
|
Phase 3 | |
Terminated |
NCT00516516 -
Oral Carnitine for Cramps in Pregnancy
|
N/A | |
Completed |
NCT04650295 -
Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial
|
N/A | |
Recruiting |
NCT03660969 -
Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease
|
||
Completed |
NCT03802565 -
Tolperisone in Acute Muscle Spasm of the Back
|
Phase 2 | |
Completed |
NCT04901832 -
Intradialytic Stretching Exercises on Prevention and Reduction of Leg Muscle Cramps
|
N/A | |
Completed |
NCT05457322 -
The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps
|
N/A | |
Terminated |
NCT04507373 -
7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events
|
Phase 4 | |
Completed |
NCT00963638 -
Beneficial Effects of Magnesium Supplementation On Idiopathic Muscle Cramps
|
N/A | |
Completed |
NCT05724485 -
Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis
|
Phase 4 |